0001209191-21-071172.txt : 20211223
0001209191-21-071172.hdr.sgml : 20211223
20211223185853
ACCESSION NUMBER: 0001209191-21-071172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211221
FILED AS OF DATE: 20211223
DATE AS OF CHANGE: 20211223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christian Waage
CENTRAL INDEX KEY: 0001553179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33221
FILM NUMBER: 211518535
MAIL ADDRESS:
STREET 1: RECEPTOS, INC.
STREET 2: 10835 ROAD TO THE CURE, SUITE 205
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/
CENTRAL INDEX KEY: 0000818033
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 942875566
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582514400
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AP PHARMA INC /DE/
DATE OF NAME CHANGE: 20010511
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-21
0
0000818033
HERON THERAPEUTICS, INC. /DE/
HRTX
0001553179
Christian Waage
4242 CAMPUS POINT COURT
SUITE 200
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2021-12-21
4
S
0
300
9.7345
D
3200
D
Common Stock
2021-12-22
4
A
0
10452
0.00
A
13652
D
Stock Option (Right to Buy)
9.81
2021-12-22
4
A
0
20903
0.00
A
2031-12-22
Common Stock
20903
20903
D
The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. The shares were sold by Mr. Waage to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on December 21, 2021.
The range of sales prices received was $9.625 to $9.945. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
The shares were granted as restricted stock units which vest in full on December 22, 2022.
The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.
/s/ Lisa Peraza
Attorney-in-fact for Christian Waage
2021-12-23